Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synovics Pharmaceuticals (SYVC) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Synovics Pharmaceuticals. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1030839.
Total stock buying since 2006: $0.
Total stock sales since 2006: $209,000.
Total stock option exercises since 2006: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2006 | 0 | $0 | 550,000 | $209,000 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2006-01 | 0 | $0 | 550,000 | $209,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-01-04 | Nostrum Pharmaceuticals, Inc. (10% Owner) | Sale | 550,000 | .38 | 209,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SYVC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synovics Pharmaceuticals (symbol SYVC, CIK number 1030839) see the Securities and Exchange Commission (SEC) website.